Seago A, Baker M H, Houghton J, Jarman M, Leung C S, Rowlands M G
Drug Development Section, Institute of Cancer Research, Sutton, Surrey, U.K.
Biochem Pharmacol. 1988 Jun 1;37(11):2167-72. doi: 10.1016/0006-2952(88)90577-1.
A homologous series of 1-n-alkyl-derivatives of aminoglutethimide (AG) has been synthesised and tested for inhibitory activity towards the cholesterol side chain cleavage enzyme (desmolase) from bovine adrenals and human placental aromatase in an attempt to find a selective aromatase inhibitor. Activity against desmolase declined from an IC50 value of 30 microM for the parent drug to 220 microM for the n-propyl derivative but increased again thereafter. Against aromatase, activity was least for the methyl and ethyl derivatives and highest (IC50 = 1.6 microM) for the hexyl and octyl analogues. The optimal ratio IC50 (desmolase):IC50 aromatase of 44 was found for the n-propyl derivative, which was therefore selected for preliminary metabolism studies using rat and mouse liver microsomes and hepatocytes and in these species in vivo. There were parallels with AG, most notably in the analogous formation from the n-propyl derivative of an arylhydroxylamine in the mouse.
已合成了氨鲁米特(AG)的一系列1 - n - 烷基衍生物的同系物,并测试了它们对牛肾上腺胆固醇侧链裂解酶(脱氨酶)和人胎盘芳香化酶的抑制活性,试图找到一种选择性芳香化酶抑制剂。对脱氨酶的活性从母体药物的IC50值30 microM下降到正丙基衍生物的220 microM,但此后又再次上升。对芳香化酶而言,甲基和乙基衍生物的活性最低,己基和辛基类似物的活性最高(IC50 = 1.6 microM)。正丙基衍生物的IC50(脱氨酶):IC50(芳香化酶)的最佳比值为44,因此选择其用于使用大鼠和小鼠肝微粒体及肝细胞以及在这些物种体内进行的初步代谢研究。与AG存在相似之处,最显著的是在小鼠体内正丙基衍生物类似地形成芳基羟胺。